STK11 and lung carcinoma: Importantly, previous studies have demonstrated that combined inhibition of MEK1/2 plus autophagy does not lead to synergistic or cooperative decreases in cell proliferation or tumor growth in a GEM model of KRASG12D/TP53Null-driven lung cancer in which LKB1 expression is retained (Bhatt et al., 2023).